Publication:
Weak association between genetic markers of hyperuricemia and cardiorenal outcomes: insights from the STANISLAS study cohort with a 20-year follow-up

dc.contributor.coauthorXhaard, C.
dc.contributor.coauthorLe Floch, E.
dc.contributor.coauthorDandine-Roulland, C.
dc.contributor.coauthorGirerd, N.
dc.contributor.coauthorFerreira, J.P.
dc.contributor.coauthorBoivin, J.M.
dc.contributor.coauthorWagner, S.
dc.contributor.coauthorBacq Daian, D.
dc.contributor.coauthorDeleuze, J.F.
dc.contributor.coauthorZannad, F.
dc.contributor.coauthorRossignol, P.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T12:12:21Z
dc.date.issued2022
dc.description.abstractBackground: Hyperuricemia is associated with poor cardiovascular outcomes, although it is uncertain whether this relationship is causal in nature. This study aimed to: (1) assess the heritability of serum uric acid (SUA) levels, (2) conduct a genome-wide association study on SUA levels, and (3) investigate the association between certain single-nucleotide polymorphisms and target organ damage. Methods and results: the STANISLAS (Suivi Temporaire Annuel Non-Invasif de la Sante des Lorrains Assures Sociaux) study cohort is a single-center longitudinal cohort recruited between 1993 and 1995 (visit 1), with a last visit (visit 4 [V4]) performed approximate to 20 years apart. Serum lipid profile, SUA, urinary albumin/creatinine ratio, estimated glomerular filtration rate, 24-hour ambulatory blood pressure monitoring, transthoracic echocardiography, pulse wave velocity, and genotyping for each participant were assessed at V4. A total of 1573 participants were included at V4, among whom 1417 had available SUA data at visit 1. Genome-wide association study results highlighted multiple single-nucleotide polymorphisms on the SLC2A9 gene linked to SUA levels. Carriers of the most associated mutated SLC2A9 allele (rs16890979) had significantly lower SUA levels. Although SUA level at V4 was highly associated with diabetes, prediabetes, higher body mass index, CRP (C-reactive protein) levels, estimated glomerular filtration rate variation (visit 1-V4), carotid intima-media thickness, and pulse wave velocity, rs16890979 was only associated with higher carotid intima-media thickness. Conclusions: our findings demonstrate that rs16890979, a genetic determinant of SUA levels located on the SLC2A9 gene, is associated with carotid intima-media thickness despite significant associations between SUA levels and several clinical outcomes, thereby lending support to the hypothesis of a link between SUA and cardiovascular disease.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue9
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuEU
dc.description.sponsorshipNancy Centre Hospitalier Regional Universitaire
dc.description.sponsorshipFrench Ministry of Health
dc.description.sponsorshipFrench National Research Agency (ANR)
dc.description.sponsorshipContrat de Plan Etat?Lorraine and Fonds Européen de Développement Régional Lorraine
dc.description.sponsorshipProgramme Hospitalier de Recherche Clinique Inter regional 2013
dc.description.sponsorshipInvestissements d’Avenir
dc.description.sponsorshipFIGHT?heart failure
dc.description.sponsorshipFrench Plan d'Investissement d'Avenir project “Lorraine Université d’Excellence
dc.description.sponsorshipEuropean Union (EU)
dc.description.sponsorshipEuropean Fibro?Targets Project
dc.description.sponsorshipEuropean HOMAGE project
dc.description.sponsorship7th Framework Program
dc.description.sponsorshipMEDIA project
dc.description.sponsorshipFOCUS?MR
dc.description.sponsorshipERA?CVD EXPERT
dc.description.sponsorshipFondation de Recherche en Hypertension Artérielle
dc.description.versionPublisher version
dc.description.volume11
dc.identifier.doi10.1161/JAHA.121.023301
dc.identifier.eissn2047-9980
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR03694
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85129781174
dc.identifier.urihttps://doi.org/10.1161/JAHA.121.023301
dc.identifier.wos789861900042
dc.keywordsCardiovascular disease
dc.keywordsGenome-wide
dc.keywordsAssociation study
dc.keywordsSingle-nucleotide Polymorphism
dc.keywordsUric acid
dc.language.isoeng
dc.publisherWiley
dc.relation.grantnoANR?15?RHU?0004
dc.relation.grantnoANR?15?IDEX?04?LUE
dc.relation.grantnoSP7#602904
dc.relation.grantno305507
dc.relation.grantno261409
dc.relation.grantnoNR?15?CE14?0032?01
dc.relation.grantnoANR?16?ECVD?0002?02
dc.relation.ispartofJournal of the American Heart Association
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10553
dc.subjectCardiovascular system and cardiology
dc.titleWeak association between genetic markers of hyperuricemia and cardiorenal outcomes: insights from the STANISLAS study cohort with a 20-year follow-up
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10553.pdf
Size:
470.03 KB
Format:
Adobe Portable Document Format